Drugs / Lactate Ringer's solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05830136 | Feb 2022 → Jan 2026 overdue | ischemic disease | The First Affiliated Hospital with Nanjing Medical University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactate Ringer's solution | “Lactate Ringer's solution was used in Group B as intraoperative intravenous fluids.” NCT05830136 ↗ |